Global warning: pharma’s role in the climate crisis
With COP26 imminent, what lessons can the pharma sector learn about its environmental impact and its response to climate change?
By
Supply Chain
Latest in
Supply Chain
Valneva could outsource Covid-19 vaccine manufacturing in response to demand
Valneva maps authorisation and manufacturing plans on the heels of positive Phase III Covid-19 vaccine data.
By
Novavax at risk of losing time advantage once Covid-19 vaccine competitors flex production muscle
Competitor protein subunit Covid-19 vaccine manufacturers are slowly closing in at Novavax’s lead.
By
Novavax Covid-19 vaccine booster: safety and manufacturing questions remain
Novavax’s Covid-19 vaccine could find its niche as a booster shot, but questions linger around its safety and production.
By
Covid-19 vaccine purchasing in EU likely to pivot to traditional reimbursement models from 2023
From 2023, Covid-19 vaccine manufacturers are likely to have to navigate each European Union (EU) member state's traditional reimbursement framework,…
By
N-SIDE on streamlining production for clinical trials
N-SIDE’s Sébastien Coppe discusses the firm’s new Production App and how it helps optimise manufacturing for clinical trials.
By
Vaxxinity CEO Mei Mei Hu on vaccine research and democratising health
Vaxxinity CEO Mei Mei Hu discusses her newly-formed company, its vaccine programmes and her mission to serve the underserved.
By
Delaying Covid-19 vaccine booster rooted in some clinical data versus reducing doses, but neither approach likely to solve distribution quandaries
Among the strategies being proposed to extend available Covid-19 vaccine supplies, delaying the second dose of an authorised two-dose vaccine…
By